middle.news
How Will Lumos’ A$5 Million Loan Accelerate FebriDx® US Launch?
10:21am on Thursday 17th of July, 2025 AEST
•
Healthcare
Read Story
How Will Lumos’ A$5 Million Loan Accelerate FebriDx® US Launch?
10:21am on Thursday 17th of July, 2025 AEST
Key Points
A$5 million secured loan facility signed with major shareholders Tenmile and Ryder Capital
Loan proceeds to replace unused A$4 million convertible note tranche
Exclusive US distribution agreement with PHASE Scientific valued at US$317 million
CLIA waiver study nearing completion with submission expected soon
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
LUMOS DIAGNOSTICS HOLDINGS (ASX:LDX)
OPEN ARTICLE